Sequent Scientific (Alivira Animal Health Ltd)

India Health

Alivira is a joint venture between Shasun Pharma and Sequent Scientific and is engaged in developing, manufacturing and marketing of animal health products and formulations.

We are invested in Sequent Scientific (Alivira Animal Health Ltd) through Ascent India Fund III, which is managed by Ascent Capital Advisors Private Limited. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts

Status:
Active
Region

Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

:
South Asia
Countries:
India
Sector

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.

:
Health
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

:
Intermediated investment
Fund:
Ascent India Fund III
Fund Manager:
Ascent Capital Advisors Private Limited
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

:
April 2014